Form 4 for CYRX Cryoport, Inc.
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001104659-22-034629 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-16 | 2022-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +10.5K | 61.8K | +20% | $0 |
| D | 2022-03-16 | 2022-03-14 | CYRX | Sawicki Mark W | CSO | A - Grant | $0.00 | +20.9K | 20.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-14 | A | A | 10,455 | $0.00 | 61,841 | D | — | — | (F1) Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. |
| 2 | Derivative | Stock Option (right to buy) | 2022-03-14 | A | A | 20,910 | $0.00 | 20,910 | D | $29.69 · — to 2029-03-14 | 20,910 Common Stock | (F2) 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022. |